MetaCap

Metagenomi Therapeutics Statistics

NASDAQ: MGXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.565-0.0488 (-7.95%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Metagenomi Therapeutics by the numbers

Metagenomi Therapeutics has a market capitalization of $21.4 million based on 37.81M shares outstanding. With trailing EPS of $-2.50, Metagenomi Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.1% below its 50-day average and 53.9% below its 200-day average.

Average daily trading volume is 163.21K shares, or about $92,216 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MGX valuation vs. peer median

MGX compared with the median of 8 peer companies
MetricMGXPeer medianDifference
Market cap$21.36M$24.77M-14%
Avg. volume163.21K140.19K+16%

Peer median across 8 companies: CVM, EVAX, SAEN, PTHS, INMB, LONA, EXOZ, ESLA.

Valuation

Market cap
$21.36M
Price / sales (latest FY)
0.85
EPS (TTM)
$-2.50

Price and trading

Previous close
0.6138
Open
0.6162
Day range
0.5621 – 0.618
52-week range
0.562 – 1.87
52-week change
-62.58%
Beta
—
Volume
274.38K

Dividends and events

Annual dividend
None
Next earnings date
Aug 13, 2025

Additional statistics

Market Cap
21.36M
Forward Pe
-0.29
Eps
-2.50
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.87
Week52 Low
0.56
Avg Volume
163.21K
Shares Outstanding
37.81M
Ma50
0.90
Ma200
1.23
Earnings Date
Aug 13, 2025
Pct From52w High
-69.79%
Pct From52w Low
0.53%

Related